Carney Lloyd

Carney Lloyd is listed in filings as Director at Vertex Pharmaceuticals Inc. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity. Recent filings connect the profile to Vertex Pharmaceuticals Inc (VRTX), Visa Inc (Ritu 1985 Trust) (V), and Grid Dynamics Holdings, Inc. (GDYN). The current snapshot covers public activity from Dec 26, 2024 to May 26, 2026. Reported amounts are shown as $1.2M to $302.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.